Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-10
DOI
10.3389/fonc.2021.726213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
- (2021) Honglei Feng et al. BMC CANCER
- A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma
- (2021) Yong Zhu He et al. Scientific Reports
- ASO Visual Abstract: The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection
- (2021) Mitsuru Yanagaki et al. ANNALS OF SURGICAL ONCOLOGY
- ASO Visual Abstract: The Impact of Histological Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
- (2021) Tatsunori Miyata et al. ANNALS OF SURGICAL ONCOLOGY
- HGF/c‐MET pathway contributes to cisplatin‐mediated PD‐L1 expression in hepatocellular carcinoma
- (2021) Zhan‐Sheng Zhang et al. CELL BIOLOGY INTERNATIONAL
- An EASL position paper for systemic treatment of hepatocellular carcinoma: Go forward courageously
- (2021) Chia-Yen Dai et al. JOURNAL OF HEPATOLOGY
- Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma
- (2021) Bo Li et al. Clinical Proteomics
- Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma
- (2020) Audrey Payancé et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402
- (2020) Atsushi Kudo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Interleukin-6 polymorphisms in HCC patients chronically infected with HCV
- (2020) Faisal Adnan et al. Infectious Agents and Cancer
- Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma
- (2020) Gabriele Ricco et al. Cancer Biomarkers
- Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy
- (2020) Shingo Shimada et al. World Journal of Surgical Oncology
- The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017
- (2020) Longfei Lin et al. Liver Cancer
- Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor differentiation
- (2020) Yuan-Quan Si et al. Infectious Agents and Cancer
- Validation of a novel model for the early detection of hepatocellular carcinoma
- (2019) Philip M. Hemken et al. Clinical Proteomics
- A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria
- (2019) Tomoki Ryu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
- (2019) Jong Man Kim et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma
- (2019) Li Yin et al. Artificial Cells Nanomedicine and Biotechnology
- PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma
- (2019) Tao Li et al. Infectious Agents and Cancer
- Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study
- (2019) Sara Tartaglione et al. Biochemia Medica
- Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC Guidelines) a 2019 update
- (2019) Norihiro Kokudo et al. HEPATOLOGY RESEARCH
- Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
- (2019) Chang Gon Kim et al. Cancer Medicine
- Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma
- (2019) Tae Seop Lim et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B
- (2019) Tian Yang et al. CLINICAL CHEMISTRY
- Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
- (2019) Caiyan Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
- (2019) Famei Qi et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Hepatitis delta virus and hepatocellular carcinoma: an update
- (2018) Raffaella Romeo et al. EPIDEMIOLOGY AND INFECTION
- Exosomal miRNAs in hepatocellular carcinoma development and clinical responses
- (2018) Shuangshuang Li et al. Journal of Hematology & Oncology
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Patient selection by tumor markers in liver transplantation for advanced hepatocellular carcinoma
- (2018) Hae Won Lee et al. LIVER TRANSPLANTATION
- Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models
- (2018) Nicha Wongjarupong et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Predictors of Microscopic Vessel Invasion Differ Between Primary Hepatocellular Carcinoma and Hepatocellular Carcinoma with a Treatment History
- (2018) Yukiyasu Okamura et al. WORLD JOURNAL OF SURGERY
- Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
- (2018) Xiao‑Lu Ma et al. Oncology Letters
- Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib; a large UK cohort
- (2018) Mehran Afshar et al. Oncotarget
- Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA
- (2018) Jiali Wu et al. Cancer Biomarkers
- Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis
- (2018) Jiu Chen et al. DISEASE MARKERS
- Epidemiology and Management of Hepatocellular Carcinoma
- (2018) Laura Kulik et al. GASTROENTEROLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study
- (2017) Nicolas Poté et al. LIVER INTERNATIONAL
- PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients
- (2017) Carlo Saitta et al. MEDICINE
- Use of Liver Imaging and Biopsy in Clinical Practice
- (2017) Elliot B. Tapper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin K and cancer
- (2017) Sofia Dahlberg et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma
- (2017) Suk-Won Suh et al. YONSEI MEDICAL JOURNAL
- Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
- (2017) Xiumei Wang et al. Infectious Agents and Cancer
- Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
- (2017) An Tang et al. Abdominal Radiology
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma
- (2016) Shu-Xiang Cui et al. CANCER INVESTIGATION
- Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern
- (2016) Feng Gao et al. Hepatobiliary & Pancreatic Diseases International
- Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasion
- (2016) Toshiro Masuda et al. HEPATOLOGY RESEARCH
- Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse®G600 analyzer
- (2016) P. Sultanik et al. JOURNAL OF VIRAL HEPATITIS
- Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization
- (2016) Takeshi Ichikawa et al. ONCOLOGY
- Risk Factors for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection
- (2016) Mitsugi Shimoda et al. WORLD JOURNAL OF SURGERY
- The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma
- (2016) J. Best et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients
- (2016) Rentao Yu et al. Scientific Reports
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Des-Gamma-Carboxy Prothrombin (DCP) Antagonizes the Effects of Gefitinib on Human Hepatocellular Carcinoma Cells
- (2015) Yu-Sheng Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma
- (2015) Mazen Noureddin et al. Clinics in Liver Disease
- Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
- (2015) Nicolas Poté et al. JOURNAL OF HEPATOLOGY
- Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
- (2015) Tae Seop Lim et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Vitamins in Pancreatic Cancer: A Review of Underlying Mechanisms and Future Applications
- (2015) Ashley H Davis-Yadley et al. Advances in Nutrition
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
- (2014) R Fox et al. BRITISH JOURNAL OF CANCER
- Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma
- (2014) Yu-Sheng Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Natural history of chronic hepatitis B virus infection
- (2014) Katrin Busch et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review
- (2013) Changzai Li et al. HEPATOLOGY RESEARCH
- Crystal Structure of Prothrombin Reveals Conformational Flexibility and Mechanism of Activation
- (2013) Nicola Pozzi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis
- (2012) Edoardo G. Giannini et al. HEPATOLOGY
- Management of HCC
- (2012) Carlos Rodríguez de Lope et al. JOURNAL OF HEPATOLOGY
- Des-γ-carboxy prothrombin and c-Met were concurrently and extensively expressed in hepatocellular carcinoma and associated with tumor recurrence
- (2012) Jianjun Gao BioScience Trends
- Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway
- (2011) Pan Yue et al. EUROPEAN JOURNAL OF CANCER
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Hepatitis B and hepatocellular carcinoma
- (2010) Adrian M. Di Bisceglie HEPATOLOGY
- Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
- (2009) A. SINGAL et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma
- (2009) M. Fujiki et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Des-γ-carboxy prothrombin stimulates human vascular endothelial cell growth and migration
- (2009) Su-Bo Wang et al. CLINICAL & EXPERIMENTAL METASTASIS
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B
- (2008) JOURNAL OF HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started